TUMORMARKERSㅣTHYROIDㅣFERTILITYㅣENDOCRINOLOGYㅣDIABETESㅣANEMIAㅣPHOSPHOCALCIC AXISㅣCARDIAC MARKERSㅣHEPATITISㅣOTHERS
 

PRODUCT

REF.
(No of tubes)

METHOD
SEPARATION

TRACER
ACT (kBq)

STANDARD
(No and Range)

CONTROLS

SAMPLE
(Vol. and type)

INCUBATIONS
(Time/T°)

SHELF-LIFE
(Labelling
periodicity)

COMMENTS

ANTI GAD AUTO-
ANTIBODIES

GAD-AB
(50)

RIA
Precipitating reagent
(Protein A)

¹²⁵ I
50

6
0 → 300U/ml

2

20μl
Serum, Plasma

2 h + 1 h
RT

6 weeks
(every 4 weeks)

Human recombinant
GAD

ANTI INSULIN AUTO-
ANTIBODIES

IA-AIA
(100)

RIA
PEG

¹²⁵ I
74

3
NEG, LOW, HIGH

0

100μl
Serum, Plasma

2 h / 37℃
+ 15′ / RT

5 weeks
(every 4 weeks)

Semi quantitative
assay

ANTI-
TYROSINE
PHOSPHATASE
AUTO-
ANTIBODIES

IA2-AB
(100)

RIA
Precipitating reagent
(Protein A)

¹²⁵ I
50

6
0 → 125U/ml

2

20μl
Serum, Plasma

20 h + 1 h
4°C

6 weeks
(every 4 weeks)

Human recombinant
IA2

C-PEPTIDE

C-PEP-CT2
(100)

RIA Competiton
Coated tubes

¹²⁵ I
185

7
0 → 5 pmol/ml

2

100μl
Serum, Plasma,
urine

2 h
RT

6 weeks
(every 4 weeks)

For urine:
Predilution 1/21 in Std 0

INSULIN

INSULIN-CT
(100)

RIA Competiton
Coated tubes

¹²⁵ I
111

7
0 → 310μU/ml

2

100μl
Serum, Plasma

20 h
RT

6 weeks
(every 4 weeks)